KAO JOHN E 4

What Happened

• John E. Kao, CEO of Alignment Healthcare, sold a total of 298,000 shares in open-market transactions on June 10, 2026. The sales were reported as two blocks: 74,936 shares at a weighted-average price of $19.65 (reported proceeds $1,472,350) and 223,064 shares at a weighted-average price of $20.60 (reported proceeds $4,594,271). Total proceeds reported: $6,066,621. These were outright sales (not purchases or option exercises).

Key Details

• Transaction dates: June 10, 2026; Form 4 filed June 12, 2026 (timely).
• Prices: weighted averages reported as $19.65 (first block) and $20.60 (second block).
  • First block sold at prices ranging $19.12–$20.11 (per filing footnote).
  • Second block sold at prices ranging $20.12–$20.89 (per filing footnote).
• Total shares sold: 298,000; total proceeds ≈ $6.07 million.
• Ownership/holdings note: footnotes indicate a transfer of 176,125 shares from Mr. Kao to the JEK Trust (dated Feb 8, 2021); the filing’s balance column reflects that transfer and that some securities are held by the JEK Trust.
• 10b5-1 plan: sales were executed under a Rule 10b5-1 trading plan adopted November 21, 2025 (footnote).
• Filing timeliness: reported within two days of the transactions (no late filing indicated).

Context

• These transactions are sales under a pre-established 10b5-1 plan, which allows insiders to trade according to a pre-set schedule; such sales are often routine and do not, by themselves, indicate the insider’s current view of the company’s prospects.
• The filing discloses weighted-average prices and price ranges; the reporting person offers to provide the exact per-price breakdown on request to the company, shareholders, or the SEC staff.